PDUFA V Implementation: A Year-By-Year Breakdown
You may also be interested in...
FDA’s Data Format Standards Approaching Cost-Benefit Analysis Stage
The agency sets a meeting for November and wants comments in advance on potential candidates for a format that will reduce the need for data integration steps between its various systems.
Woodcock Says Blowing Up Orphan Drug Act Not Advisable In Current Climate
FDA appears just as nervous as the National Organization for Rare Disorders about what Congress would do if asked to tweak the Orphan Drug Act.
Woodcock Says Blowing Up Orphan Drug Act Not Advisable In Current Climate
FDA appears just as nervous as the National Organization for Rare Disorders about what Congress would do if asked to tweak the Orphan Drug Act.